
Nigeria has become the 34th African Union member state to ratify the African Medicines Agency (AMA) Treaty, a move expected to strengthen medicines regulation and improve public health across the continent.
The announcement was made by the African Union Commissioner for Health, Humanitarian Affairs and Social Development, Ambassador A. Twum-Amoah, during the inaugural AMA Week in Kigali, Rwanda, which runs from 25 to 30 October, 2026.
The Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), Professor Mojisola Christianah Adeyeye, described the development as a major step towards improving access to safe and quality medicines in Africa.
According to Adeyeye, Nigeria’s participation would support efforts to harmonise medicines regulation across African countries, particularly in tackling substandard and falsified medical products.
She added that the ratification would also promote pharmaceutical innovation, strengthen local drug manufacturing and improve health security across the continent.
Adeyeye noted that the development creates opportunities for closer collaboration between NAFDAC, the AMA and other national and regional regulatory bodies.
She stressed the need to translate the ratification into practical action through information sharing, scientific cooperation, regulatory capacity development and stronger institutional partnerships.
The NAFDAC boss said the success of the AMA would depend on its ability to ensure that Africans have access to safe, effective, quality-assured and affordable medicines.
She further explained that the effectiveness of the agency would depend partly on the capacity and maturity of national medicines regulatory authorities across the continent.
Adeyeye described Nigeria’s ratification as more than a diplomatic achievement, saying it represents an investment in Africa’s health security, pharmaceutical independence and sustainable development.





